+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Procalcitonin"

From
From
Sepsis Diagnostics Products and Market Trends - Product Thumbnail Image

Sepsis Diagnostics Products and Market Trends

  • Report
  • October 2020
  • 58 Pages
  • Global
From
Analysing Sepsis Management Part I: Diagnosis - Product Thumbnail Image

Analysing Sepsis Management Part I: Diagnosis

  • Report
  • June 2020
  • 48 Pages
  • Global
From
From
From
Biomarkers in Medicine - Product Thumbnail Image

Biomarkers in Medicine

  • Book
  • September 2022
Biomarkers - Technologies, Markets & Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets & Companies

  • Report
  • November 2021
  • 1032 Pages
  • Global
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Procalcitonin is a biomarker used in genomics to measure the severity of bacterial infections. It is a peptide hormone produced by the thyroid gland and is released in response to bacterial infections. Procalcitonin is used to differentiate between bacterial and viral infections, and to monitor the progression of bacterial infections. It is also used to determine the need for antibiotics and to monitor the effectiveness of antibiotic therapy. Procalcitonin testing is becoming increasingly popular in the genomics market due to its ability to provide accurate and timely diagnosis of bacterial infections. It is also used to reduce the risk of antibiotic resistance, as it can help to identify the most appropriate antibiotic for a particular infection. Several companies are involved in the Procalcitonin market, including Abbott, Siemens, Roche, and Thermo Fisher Scientific. These companies offer a range of products, including Procalcitonin assays, kits, and reagents. Show Less Read more